75N95024F00003↗

Name: 75N95024F00003: CTN'S Clinical Coordinating Center Contract. CTN Study, Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (Ctn-0100). Pop: 8/15/24 - 4/2/28
Creator: SpendQuery

CTN'S CLINICAL COORDINATING CENTER CONTRACT. CTN STUDY, OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). POP: 8/15/24 - 4/2/28

Delivery Order · National Institutes of Health · to The Emmes Company, LLC (UEI NBQCBJ6FXBU4) · data as of 2026-09-30

Obligated to date$3.94M2 actions

Current value$3.94Mwith options exercised

Period2024-08-15 → 2028-04-02current end date

Up for re-bid: ends 2028-04-02. Recompete brief →

What it is

Product or service: Health R&D Services; Health Care Services; Basic Research (PSC AN11)
Industry: Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) (NAICS 541715)
Contracting office: National Institutes of Health Nida (75N950)
Competition: Full and open competition
Pricing: Cost plus fixed fee
How it was bought: Single-award IDIQ · under 75N95024D00037
Solicitation: 75N95024R00025
Where the work is: Montgomery, MD · district MD-08
Topics: opioids

Obligations by fiscal year

FY2024$3.42M

FY2026$525.0K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

2 actions since 2024-08-13. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-06-29	P00001	Funding only	$525.0K	CTN'S CLINICAL COORDINATING CENTER CONTRACT. CTN STUDY, OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). POP: 8/15/24 - 4/2/28
2024-08-13	0		$3.42M	CTN'S CLINICAL COORDINATING CENTER CONTRACT. CTN STUDY, OPTIMIZING RETENTION, DURATION AND DISCONTINUATION STRATEGIES FOR OPIOID USE DISORDER PHARMACOTHERAPY (CTN-0100). POP: 8/15/24 - 4/2/28

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗